Biotech developers Animated Dynamics, Predictive Wear and Brightlamp have all secured commitments worth up to $250,000 from Foundry Investment Fund.

Columbia University has granted a new licence to its cardiovascular research platform spinout Tara Biosystems, which markets services powered by is "heart-on-a-chip" tissue modelling system.

The university's new $100m Pritzker School of Molecular Engineering will aim to kindle the advancement of novel technologies in partnership with the Polsky Center for Entrepreneurship and Innovation.

Qbic has participated in a $32.8m funding round for EyeD, consisting of $9.4m in equity and another $23.4m in debt financing and government grants.

Mitsui Sumitomo is set to participate in a series B round for the online medical products marketplace that will be sized at $28.6m.

The cancer drug developer has closed a series B round led by development partner Novartis that included Harel Insurance and Finance and SBI JI Innovation Fund.

Solid tumour treatment developer Atreca has set a $100m target for an initial public offering that will provide GlaxoSmithKline with an exit.

Personalis has filed to list on the Nasdaq Global Market through an offering that would come eight years after the genome sequencing platform was spun out of Stanford University.

Steady is the assessment that comes to mind, rather than remarkable, when probing the year-on-year direction of corporate venture capital investment in university spinouts.

DesertDx has spun out of UA's Tech Launch Arizona to commercialise a comprehensive single blood-draw diagnostics test for lung cancer.